5 hours ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX’s Comirnaty Zacks
Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared with treatment with Comirnaty.
Coronavirus · Moderna (MRNA) · Pfizer (PFE)